Skip to content
10-Q

Quarterly Report

Metagenomi Therapeutics, Inc. MGX

0001193125-25-276150

← back to feed
Filed
Nov 12, 2025 12:00 AM ET
Period of report

On SEC.gov

Financials in this filing

Metric Period Value
Shares Outstanding Q3 2025 · Nov 5, 2025 0 sh
Shares Diluted Q3 2025 · Sep 30, 2025 37.35M sh
Shares Diluted Q3 2025 · Sep 30, 2025 37.18M sh
Shares Diluted Q3 2025 · Sep 30, 2024 36.77M sh
Shares Diluted Q3 2025 · Sep 30, 2024 31.6M sh
Capex Q3 2025 · Sep 30, 2025 $489K
Capex Q3 2025 · Sep 30, 2024 $2.78M
Operating Cash Flow Q3 2025 · Sep 30, 2025 −$65.35M
Operating Cash Flow Q3 2025 · Sep 30, 2024 −$82.8M
Cash And Equivalents Q3 2025 · Sep 30, 2025 $32.77M
Cash And Equivalents Q3 2025 · Dec 31, 2024 $27.39M
Cash And Equivalents Q3 2025 · Sep 30, 2024 $25.12M
Stockholders Equity Q3 2025 · Sep 30, 2025 $178.45M
Stockholders Equity Q3 2025 · Jun 30, 2025 $195.83M
Stockholders Equity Q3 2025 · Mar 31, 2025 $212.66M
Stockholders Equity Q3 2025 · Dec 31, 2024 $234.86M
Stockholders Equity Q3 2025 · Sep 30, 2024 $255.77M
Stockholders Equity Q3 2025 · Jun 30, 2024 $269.42M
Stockholders Equity Q3 2025 · Mar 31, 2024 $275.63M
Stockholders Equity Q3 2025 · Dec 31, 2023 −$135.58M
Current Liabilities Q3 2025 · Sep 30, 2025 $29.58M
Current Liabilities Q3 2025 · Dec 31, 2024 $37.31M
Total Liabilities Q3 2025 · Sep 30, 2025 $69.49M
Total Liabilities Q3 2025 · Dec 31, 2024 $89.74M
Current Assets Q3 2025 · Sep 30, 2025 $189.82M
Current Assets Q3 2025 · Dec 31, 2024 $257.96M
Total Assets Q3 2025 · Sep 30, 2025 $247.94M
Total Assets Q3 2025 · Dec 31, 2024 $324.6M
Eps Diluted Q3 2025 · Sep 30, 2025 −$0.55
Eps Diluted Q3 2025 · Sep 30, 2025 −$1.76
Eps Diluted Q3 2025 · Sep 30, 2024 −$0.51
Eps Diluted Q3 2025 · Sep 30, 2024 −$1.73
Eps Basic Q3 2025 · Sep 30, 2025 −$0.55
Eps Basic Q3 2025 · Sep 30, 2025 −$1.76
Eps Basic Q3 2025 · Sep 30, 2024 −$0.51
Eps Basic Q3 2025 · Sep 30, 2024 −$1.73
Sga Expense Q3 2025 · Sep 30, 2025 $6.22M
Sga Expense Q3 2025 · Sep 30, 2025 $20.01M
Sga Expense Q3 2025 · Sep 30, 2024 $7.64M
Sga Expense Q3 2025 · Sep 30, 2024 $24.94M
Rd Expense Q3 2025 · Sep 30, 2025 $25.28M
Rd Expense Q3 2025 · Sep 30, 2025 $72.93M
Rd Expense Q3 2025 · Sep 30, 2024 $26.26M
Rd Expense Q3 2025 · Sep 30, 2024 $86.02M
Net Income Q3 2025 · Sep 30, 2025 −$20.39M
Net Income Q3 2025 · Sep 30, 2025 −$65.34M
Net Income Q3 2025 · Jun 30, 2025 −$19.91M
Net Income Q3 2025 · Mar 31, 2025 −$25.04M
Net Income Q3 2025 · Sep 30, 2024 −$18.77M
Net Income Q3 2025 · Sep 30, 2024 −$54.66M
Net Income Q3 2025 · Jun 30, 2024 −$10.74M
Net Income Q3 2025 · Mar 31, 2024 −$25.15M
Operating Income Q3 2025 · Sep 30, 2025 −$22.84M
Operating Income Q3 2025 · Sep 30, 2025 −$71.65M
Operating Income Q3 2025 · Sep 30, 2024 −$22.38M
Operating Income Q3 2025 · Sep 30, 2024 −$68.28M
Revenue Q3 2025 · Sep 30, 2025 $8.66M
Revenue Q3 2025 · Sep 30, 2025 $21.3M
Revenue Q3 2025 · Sep 30, 2024 $11.51M
Revenue Q3 2025 · Sep 30, 2024 $42.68M